Drugs in Development: From Pipeline to MarketPharmaLive Special ReportsJune 18, 2009 140 Pages - SKU: ENPP2298710 |
| This annual report developed by the editors of PharmaLive provides detailed information on prescription drugs in development and those currently on the market.
Easy to read charts provide a complete overview of prescription drugs in development and on the market in the United States, including new chemical entities, indications, and formulations approved from June 2008 to April 2009.
Drugs are organized by their approved or development status. Each section provides:
|
Related Markets
Drug Discovery Reports
- Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
- Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012
